Disclaimer

The purpose of this corporate presentation (the "Presentation") is to provide an overview of Genoptic Solartech EU Ltd. and its related entities (collectively, “Genoptic" or the "Company"). This presentation is being provided on a confidential basis solely for the information of those persons to whom it is given. The materials, including the information contained herein, may not be copied, reproduced, republished, posted, transmitted, distributed, disseminated, or disclosed, in whole or in part, to any other person in any way without the prior written consent of the Company, which the Company is under no obligation to provide and may without consent for any reason whatsoever. By accepting this presentation, you agree that you will comply with these confidentiality restrictions and acknowledge that your compliance is a material inducement to the Company providing this presentation to you. The Company has used its best efforts to ensure the accuracy and completeness of the information presented, however the Company expressly disclaims any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained herein; (ii) any error, omission or inaccuracy in any such information; or (iii) any action resulting therefrom.

Certain statements contained in this Presentation may constitute forward-looking information and statements. All statements in this Presentation, other than statements of historical fact that address events or developments concerning the Company that the Company expects to occur are "forward-looking information and statements". Forward-looking information and statements are often, but not always, identified by the use of words such as "anticipate", "believe", "plan", "execute", "expect", "future", "will", "project", "propose", "target", "complete", "implement", "forecast", "should", "create" and "propose", and similar expressions and variations (including negative variations). The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. 

In particular, but without limiting the foregoing, this Presentation may contain forward looking information and statements pertaining to the following: Genoptic’s business prospects or opportunities, services and strategies Genoptic is pursuing; market trends; the expected performance of Genoptic’s business and operations; the future liquidity, financial capacity and financial performance of Genoptic; expectations regarding Genoptic’s ability to obtain financing; use of proceeds from financings; and projected costs associated with the planned business activities and the opening of new production lines. Forward-looking statements and information are based on certain key expectations and assumptions concerning Genoptic’s ability to complete its capital raising activities, the continued demand for its products, the successful execution on letters of intent with third parties and the successful execution of its European joint venture. Although Genoptic believes that the expectations and assumptions on which such forward-looking statements and information are reasonable, readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. 

Actual results could differ materially from those currently anticipated due to a number of factors and risks. Such factors may include, but are not limited to, Genoptic not being able to complete its capital raising activities, Genoptic not being able to obtain required regulatory and/or governmental approvals for any desired operational activities, changes in regulatory policy and compliance requirements, changes in industry conditions, changes in economic conditions in and around target market areas, labour and/or equipment shortages, delays or changes in plans with respect to planned capital expenditures, fluctuations in input prices, fluctuations in relationships with existing and potential partners, ability to secure relationships with certain targeted parties, changes in strategy and offerings of competitors, number of competitors in Genoptic’s target markets, fluctuations in business development and supply chain, fluctuations in foreign currency exchange rates, fluctuations in interest rates, reliance on industry partners and other factors that may be beyond Genoptic’s control. 

The preceding list is not exhaustive of all possible factors. Should one or more of the above noted risks or uncertainties materialize, or should any underlying assumptions provide incorrect or materially differ, actual results, performance or achievements of Genoptic or industry results, may vary materially from those described in this Presentation. Readers are cautioned that the foregoing list of factors is not exhaustive. All of the forward-looking information and statements contained in this Presentation are qualified by these cautionary statements. The reader of this Presentation is cautioned not to place undue reliance on any forward-looking information and statements. Genoptic expressly disclaims any intention or obligation to update or revise any forward-looking information and statements, whether as a result of new information, events or otherwise, except in accordance with applicable securities laws. The content of this Presentation has not been approved by any securities commission or regulatory authority in Canada, or any other jurisdiction.

This is not an offer to sell or a solicitation of an offer to purchase securities by Genoptic. By agreeing to receive this Presentation, you agree to be bound by the provisions of this disclaimer. Any subsequent offer to sell or solicitation of an offer to purchase securities by Genoptic, if at all, will be made by means of offering documents (e.g., term sheet, prospectus, offering memorandum, subscription agreement and or similar documents (collectively, the "Offering Documents")) prepared by Genoptic for use in connection with such subsequent offer or solicitation and only in jurisdictions where permitted by law. In the event of a subsequent offer to sell or solicitation of an offer to purchase securities by Genoptic, investors should refer to the Offering Documents for more complete information, including investment risks, management fees and fund expenses. The attached material is provided for informational purposes only as of the date hereof, is not complete, and may not contain certain material information about Genoptic, including important disclosures and risk factors associated with an investment in Genoptic. This information does not take into account the particular investment objectives or financial circumstances of any specific person who may receive it. In the event of a subsequent offer to sell or a solicitation of an offer to purchase securities by Genoptic, more complete disclosures and the terms and conditions relating to a particular investment will be contained in the Offering Documents prepared for such offer or solicitation. Before making any investment, prospective investors should thoroughly and carefully review the Offering Documents with their financial, legal and tax advisors to determine whether an investment is suitable for them.